ArticleJournal of sleep research2026
Psychometric Properties of the PROMIS Pediatric Sleep Disturbance and Sleep-Related Impairment Self and Proxy Short Forms in Early Adolescents With and Without ADHD.
Article in Journal of sleep research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
This study evaluated the psychometric properties and psychopathology correlates of the Patient-Reported Outcome Measurement Information System (PROMIS) Pediatric Sleep Disturbance and Sleep-related Impairment Self and Proxy Short Forms in early adolescents with and without attention-deficit/hyperactivity disorder (ADHD). Participants were 341 early adolescents (ages 10-12 years; 52.2% female), with approximately half meeting diagnostic criteria for ADHD. Adolescents and their caregivers completed short form versions of the PROMIS Pediatric Sleep Disturbance and Sleep-related Impairment Self and Proxy Forms, in addition to measures of ADHD, anxiety, and depressive symptoms. Adolescents with ADHD were significantly more likely to be taking melatonin (33.7%) compared to adolescents without ADHD (14.9%). Across informants, the PROMIS paediatric sleep measures demonstrated strong internal consistency, moderate convergent validity, and partial evidence of discriminant validity. As expected, adolescents with ADHD had higher scores in both sleep disturbance and sleep-related impairment than their non-ADHD peers across both informants, and most differences remained when participants taking stimulant medications were excluded from analyses. No sex differences in either sleep disturbance or sleep-related impairment scores were present across either adolescent or parent informant. Both sleep disturbance and sleep-related impairment were consistently associated with higher levels of psychopathology across parent, teacher, and adolescent reports, with daytime impairment showing particularly strong and unique associations with depression. This study provides psychometric support for the PROMIS Pediatric Sleep Disturbance and Sleep-related Impairment Self and Proxy Short Forms in early adolescents, including youth with ADHD who frequently experience sleep disturbances and sleep-related impairment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.